PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In a rat model, wound contraction was significantly lower in the tamanu group compared to control and Centella asiatica groups [PMID:34597168].
Clinical tests confirmed UV-protective effects with SPF and PA values of 6.3 ± 0.4 and 2.9 ± 0.6, respectively [PMID:41222861]. In vitro testing showed an SPF of 21.5 [PMID:42084842].
A levocetirizine-loaded emulgel containing tamanu oil showed enhanced therapeutic potential in reducing scratching frequency and erythema scores in vivo compared to conventional gel [PMID:31238752].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35069754 (2021) — Potential of Tamanu (Calophyllum inophyllum) Oil for Atopic Dermatitis Treatment. · Evidence-based complementary and alternative medicine : eCAM
- 2.PMID: 27280931 (2016) — Biological Activity of Polynesian Calophyllum inophyllum Oil Extract on Human Skin Cells. · Planta medica
- 3.PMID: 31198623 (2019) — Chemodiversity of Calophyllum inophyllum L. oil bioactive components related to their specific geographical distribution in the South Pacific region. · PeerJ
- 4.PMID: 34597168 (2021) — Evaluation of the cutaneous wound healing potential of tamanu oil in wounds induced in rats. · Journal of wound care
- 5.PMID: 33573143 (2021) — Improving the Antioxidant Properties of Calophyllum inophyllum Seed Oil from French Polynesia: Development and Biological Applications of Resinous Ethanol-Soluble Extracts.